Literature DB >> 27614086

Values of radiological examinations for the diagnosis and prognosis of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary diseases.

Linna Huang1,2, Hangyong He1, Yi Ding3, Jingjing Jin1, Qingyuan Zhan2.   

Abstract

INTRODUCTION: The important role of radiological examinations of invasive pulmonary aspergillosis (IPA) in patients with neutropenia has been well studied; however, little is known about IPA in critically ill chronic obstructive pulmonary disease (COPD) patients.
OBJECTIVES: To evaluate the value of radiological examinations in the diagnosis and prognosis of invasive bronchial-pulmonary aspergillosis (IBPA) in critically ill COPD patients.
METHODS: We included 61 critically ill COPD patients in the intensive care unit (ICU) in a retrospective, single-center cohort study.
RESULTS: All of the patients were classified as IBPA group (n = 21) or non-IBPA group (n = 40). The chest computed tomography (CT) image analysis showed that the IBPA group had the highest percent of patchiness (76.2%), followed by multiple nodules (33.3%), angio-invasive patterns (including halo sign, wedge consolidation and air-crescent sign/cavity with a relatively low percent of 19%, 19% and 28.5%, respectively), and the multiple nodules that were distributed along the airway provided the most specific image, with the highest specificity of 92.5%. Compared to the survivors in the IBPA group, non-surviving patients had a higher percent of large consolidation (0% vs. 45.5%, P = .035). When the new effusions appeared on a chest x-ray (CXR), the creatinine (140.4 μmol/L vs. 64.0 μmol/L, P = .010) and PaO2 /FiO2 (188 mm Hg vs. 222 mm Hg, P = .034) rate deteriorated.
CONCLUSIONS: Multiple nodules that were distributed along with broncho-vascular bundles were relatively common and specific in critically ill COPD patients with IBPA. Deteriorated CXR combined with specific laboratory examinations, even when appropriate antibiotics were used, could indicate a diagnosis of IBPA. Large consolidations might be considered as poor prognostic indicators.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  aspergillus; chronic obstructive pulmonary disease; invasive bronchial-pulmonary aspergillosis; radiology

Mesh:

Year:  2016        PMID: 27614086     DOI: 10.1111/crj.12551

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  6 in total

1.  In Vitro Evaluation of Radiolabeled Amphotericin B for Molecular Imaging of Mold Infections.

Authors:  Sebastian Wurster; Samuel Samnick; Lukas Page; Andrew J Ullmann; Fabian Schadt
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

2.  Rapidly progressing dual infection with Aspergillus and Rhizopus: when soil inhabitants become deadly invaders.

Authors:  Milind Bhagat; Alwyn Rapose
Journal:  BMJ Case Rep       Date:  2016-12-08

3.  Multiple cavities with halo sign in a case of invasive pulmonary aspergillosis during therapy for drug-induced hypersensitivity syndrome.

Authors:  Tomoo Ikari; Katsura Nagai; Masashi Ohe; Toshiyuki Harada; Yasushi Akiyama
Journal:  Respir Med Case Rep       Date:  2017-04-19

4.  Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria.

Authors:  Linna Huang; Hangyong He; Jingjing Jin; Qingyuan Zhan
Journal:  BMC Infect Dis       Date:  2017-03-14       Impact factor: 3.090

Review 5.  Molecular Imaging of Invasive Pulmonary Aspergillosis Using ImmunoPET/MRI: The Future Looks Bright.

Authors:  Christopher R Thornton
Journal:  Front Microbiol       Date:  2018-04-09       Impact factor: 5.640

6.  Airway-invasion-associated pulmonary computed tomography presentations characteristic of invasive pulmonary Aspergillosis in non-immunocompromised adults: a National Multicenter Retrospective Survey in China.

Authors:  Zhibo Liu; Yuping Li; Xinlun Tian; Qinghua Liu; Erran Li; Xiaoying Gu; Min Liu; Jiuyang Xu; Zhiyi He; Yi Huang; Shuyun Xu; Guoxiang Lai; Yusheng Chen; Xiangyan Zhang; Tiantuo Zhang; Jinfu Xu; Lanyan Zhu; Jieming Qu; Bin Cao
Journal:  Respir Res       Date:  2020-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.